Xiamen Amoytop Biotech Co., Ltd. is a biopharmaceutical company that specializes in the research, production and sale of recombinant proteins and long-lasting modified drugs. The company’s launched products include polyglycol interferon α-2b injection, recombinant human granulocytomestome injection, injection recombinant human granulocytosis macrophage stimulator and injection recombinant human leukone-11. The company was founded in 1996, and headquartered in Xiamen City, China.
Headquarters
No. 330, Weng Jiao Road, Haicang Xinyang Industrial Zone, Xiamen City, Fujian Province
Xiamen; Fujian;
Postal Code: 361028
Contact Details: Purchase the Xiamen Amoytop Biotech Co., Ltd. report to view the information.
Website: http://www.amoytop.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service